Evidence map›Paper›PMID 29027019›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2018

Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort.

Claus-Jürgen Scholz, Heike Weber, Susanne Jungwirth, Walter Danielczyk, Andreas Reif, Karl-Heinz Tragl, Peter Fischer, Peter Riederer, Jürgen Deckert, Edna Grünblatt

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Alzheimer's disease multi-ancestry genome-wide interaction and stratified study with smoking.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. ThePharmacogenomics · 2019
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Claus-Jürgen ScholzCore Unit Systems Medicine, University Hospital of Würzburg, Würzburg, Germany.
Heike WeberDepartment of Psychiatry, Psychosomatics, Psychotherapy, University Hospital Frankfurt/Main, Frankfurt/Main, Germany.
Susanne JungwirthLudwig Boltzmann Society, L. Boltzmann Institute of Aging Research, Vienna, Austria.
Walter DanielczykLudwig Boltzmann Society, L. Boltzmann Institute of Aging Research, Vienna, Austria.
Andreas ReifDepartment of Psychiatry, Psychosomatics, Psychotherapy, University Hospital Frankfurt/Main, Frankfurt/Main, Germany.
Karl-Heinz TraglLudwig Boltzmann Society, L. Boltzmann Institute of Aging Research, Vienna, Austria.
Peter FischerLudwig Boltzmann Society, L. Boltzmann Institute of Aging Research, Vienna, Austria.
Peter RiedererCenter of Mental Health, Clinic and Policlinic of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany.
Jürgen DeckertCenter of Mental Health, Clinic and Policlinic of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany.
Edna GrünblattCenter of Mental Health, Clinic and Policlinic of Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Würzburg, Würzburg, Germany. edna.gruenblatt@kjpd.uzh.ch.ORCID 0000-0001-8505-7265
Ludwig Boltzmann Gesellschaft · ATUniversitätsklinikum Würzburg · DEGoethe University Frankfurt · DEUniversity of Zurich · CH

Funding

Alzheimer Forschung Initiative 09802Interdisziplinäres Zentrum für Klinische Forschung (IZKF Z-6Ludwig Boltzmann Institute of Aging Research N.A.
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder that preferentially affects individuals of advanced age. Heritability estimates for AD range between 60 and 80%, but only few genetic risk factors have been identified so far. In the present explorative study, we aimed at characterizing the genetic contribution to late-onset AD in participants of the Vienna Transdanube Aging (VITA) longitudinal birth cohort study in a two-step approach. First, we performed a genome-wide screen of pooled DNA samples (n = 588) to identify allele frequency differences between AD patients and non-AD individuals using life-time diagnoses made at the age of 80 (t = 60 months). This analysis suggested a high proportion of brain-expressed genes required for cell adhesion, cell signaling and cell morphogenesis, and also scored in known AD risk genes. In a second step, we confirmed associations using individual genotypes of top-ranked markers examining AD diagnoses as well as the dimensional scores: FULD and MMSE determined up to the age of 82.5 (t = 90 months). Taken together, our study proposes genes ANKS1B, ENST00000414107, LOC100505811, SLC22A14, QRFPR, ZDHHC8P1, ADAMTS3 and PPFIA1 as possible new candidates involved in the etiology of late-onset AD, with further research being needed to clarify their exact roles.

Indexed as

AgedAged, 80 and overAgingAlzheimer DiseaseAustriaCohort StudiesFemaleGenetic LociGenetic Predisposition to DiseaseGenetic TestingHumansLongitudinal StudiesMaleAlzheimer’s diseaseCandidate gene identificationCohort studyGenotyping microarrayPooled DNA analysis

Identifiers

PMID29027019
OpenAlexW2760902463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.